Literature DB >> 4026579

Formation, toxicity and inactivation of acrolein during biotransformation of cyclophosphamide as studied in freshly isolated cells from rat liver and kidney.

Y Ohno, K Ormstad.   

Abstract

In the present study the formation and the effects of cyclophosphamide-derived acrolein were investigated using isolated cells from rat liver and kidney, with particular regard to the protective action of low molecular weight thiols against cellular toxicity. The results may be summarized as follows: Cyclophosphamide (CTX)-mediated toxicity to isolated cells is dependent on cytochrome P-450 activity; Loss of viability in cells incubated with cyclophosphamide is preceded by a depletion of cellular GSH; Stimulation of cellular GSH synthesis or the presence of low molecular weight thiols in the incubation medium protects against cyclophosphamide-induced toxicity; Acrolein is probably formed extracellularly as well as intracellularly and can be detoxified by thiol compounds, forming a thiochemiacetal or a thioether.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026579     DOI: 10.1007/bf00343118

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  19 in total

1.  Use of isolated kidney cells for study of drug metabolism.

Authors:  D P Jones; G B Sundby; K Ormstad; S Orrenius
Journal:  Biochem Pharmacol       Date:  1979-03-15       Impact factor: 5.858

2.  A correlation between glutathione levels and cellular damage in isolated hepatocytes.

Authors:  J Högberg; A Kristoferson
Journal:  Eur J Biochem       Date:  1977-03-15

3.  Isolation and use of liver cells.

Authors:  P Moldéus; J Högberg; S Orrenius
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides.

Authors:  D J Reed; J R Babson; P W Beatty; A E Brodie; W W Ellis; D W Potter
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

5.  The enzymatic basis of the selective action of cyclophosphamide.

Authors:  P J Cox; B J Phillips; P Thomas
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

6.  Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.

Authors:  H L Gurtoo; J H Hipkens; S D Sharma
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

7.  The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.

Authors:  H J Hohorst; U Draeger; G Peter; G Voelcker
Journal:  Cancer Treat Rep       Date:  1976-04

8.  Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.

Authors:  M J Berrigan; A J Marinello; Z Pavelic; C J Williams; R F Struck; H L Gurtoo
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  Interaction of cyclophosphamide metabolites with membrane proteins: an in vitro study with rabbit liver microsomes and human red blood cells. Effect of thiols.

Authors:  D B Wildenauer; C E Oehlmann
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

10.  The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.

Authors:  N Brock
Journal:  Recent Results Cancer Res       Date:  1980
View more
  5 in total

1.  Oral glutamine attenuates cyclophosphamide-induced oxidative stress in the bladder but does not prevent hemorrhagic cystitis in rats.

Authors:  Premila Abraham; Bina Isaac; Hemalatha Ramamoorthy; Kasthuri Natarajan
Journal:  J Med Toxicol       Date:  2011-06

2.  L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.

Authors:  J C Roberts; D J Francetic; R T Zera
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease.

Authors:  Chava B Pocernich; D Allan Butterfield
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  Effect of diethyldithiocarbamate in cyclophosphamide-induced nephrotoxicity: Immunohistochemical study of superoxide dismutase 1 in rat.

Authors:  Vaibhav G Sheth; Umashanker Navik; Krishna Prahlad Maremanda; Gopabandhu Jena
Journal:  Indian J Pharmacol       Date:  2018 Jan-Feb       Impact factor: 1.200

5.  Nano-Structured Lipid Carrier-Based Oral Glutathione Formulation Mediates Renoprotection against Cyclophosphamide-Induced Nephrotoxicity, and Improves Oral Bioavailability of Glutathione Confirmed through RP-HPLC Micellar Liquid Chromatography.

Authors:  Adel M Ahmad; Hamdoon A Mohammed; Tarek M Faris; Abeer S Hassan; Hebatallah B Mohamed; Mahmoud I El Dosoky; Esam M Aboubakr
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.